Additionally, to investigate the correlations between SERPINB2 and CSC populations in various cancer patients, we analyzed the co-expression of SERPINB2 in CD44-, CD133- or ALDH-positive tissue samples from breast, colorectal and liver cancer patients, respectively. Here, SERPINB2 is linked to cancer.